Pathogenetic and clinical significance of the gut-liver microbiota axis

Author:

Dicheva D. T.1ORCID,Andreev D. N.1ORCID

Affiliation:

1. Yevdokimov Moscow State University of Medicine and Dentistry

Abstract

Today, nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) account for more than 50% of chronic liver diseases and cirrhosis in developed countries. The clinical significance of these pathologies lies in the formation of liver fibrosis and, therefore, in the increased risk of liver cirrhosis and hepatocellular carcinoma, which are life-threatening conditions. NAFLD is based on obesity and insulin resistance, whereas alcohol consumption is central to the etiopathogenesis of ALD. Recently, the role of the gut-liver microbiota axis in the genesis of NAFLD and ALD has also received increasing attention. Changes in qualitative and quantitative composition of intestinal microbiota and alterations of barrier function of intestinal mucosa can lead to entry of intraluminal antigens through portal vein system into the liver, inducing damage to hepatocytes and activation of proinflammatory processes. It is shown that in patients with CLD (NAFLD and ALD) there is an increase in  the permeability of the intestinal mucosa and dysbiotic changes of the intestinal microbiome. The role of the gut-liver microbiota axis is well described in the genesis of NAFLD and ALD. Chronic alcohol consumption leads to increased colonies of Gram-negative bacteria in the intestinal mucosa and, therefore, to the accumulation of endotoxins (lipopolysaccharide components of bacterial cell membranes). Acetaldehyde produced by ADH of the intestinal epithelium stimulates tyrosine phosphorylation of tight cell contacts, increasing intestinal mucosal permeability, which leads to translocation of endotoxins into the portal bloodstream. Obesity is a major risk factor for NAFLD, which is also associated with dysbiotic changes in the intestinal microbiome. Obese individuals have increased Firmicutes, decreased Bacteroidetes, mediated reduction of short-chain fatty acid synthesis and increased intestinal wall permeability due to disruption of intercellular dense contacts, which leads  to increased translocation of bacteria and endotoxins into the systemic bloodstream.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference44 articles.

1. Komova A., Maevskaya M., Ivashkin V. Prevalence of Liver Disease in Russia’s Largest City: A Population-based Study. Am J Clin Med Res. 2014;2(5):99–102. Available at: https://www.researchgate.net/publication/280769675_Prevalence_of_Liver_Disease_in_Russias_Largest_City_A_Population-based_Study.

2. Blachier M., Leleu H., Peck-Radosavljevic M., Valla D.-C., Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58(3):593–608. https://doi.org/10.1016/j.jhep.2012.12.005.

3. Setiawan V.W., Stram D.O., Porcel J., Lu S.C., Le Marchand L., Noureddin M. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort. Hepatology. 2016;64(6):1969–1977. https://doi.org/10.1002/hep.28677.

4. Ivashkin V.T., Drapkina O.M., Mayev I.V., Trukhmanov A.S., Blinov D.V., Palgova L.K. et al. Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results. Russian Journal of Gastroen­ terology, Hepatology, Coloproctology. 2015;25(6):31–41. (In Russ.) Available at: http://old-gastro-j.ru/article/684-h2-rasprostranennost-nealkogolnoy-zhirovoy-bolezni-pecheni-u-patsientov-ambulatorno-polikliniche/show/full.

5. Maev I.V., Andreev D.N., Dicheva D.T., Kuznetsova E.I. Nonalcoholic fatty liver disease. Moscow: Prima Print; 2017. 64 p. (In Russ.) Available at: https://docplayer.com/52977167-I-v-maev-d-n-andreev-d-t-dicheva-e-i-kuznecova-nealkogolnaya-zhirovaya-bolezn-pecheni-posobie-dlya-vrachey.html.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3